Daniel Camardo
Vermögen: 556 336 $ am 31.08.2026
Vermögen: 556 336 $ am 31.08.2026
Mr. Daniel A. Camardo is on the Board of Directors at Cue Biopharma, Inc. and CommunityHealth NFP.
Mr. Camardo was previously employed as a President-North America by Immedica Pharma AB, a Chief Executive Officer, Secretary, Director & CAO by Athersys, Inc., a President-US & Executive Vice President by Horizon Therapeutics Ltd. (Ireland), a Vice President-Sales & Operations by Clarus Therapeutics, Inc., and a Senior Director-US Commercial Operations by Astellas Pharma US, Inc. He received his undergraduate degree from Rochester Christian University and an MBA from Kellogg School of Management.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CUE BIOPHARMA, INC. 0,3 % | 09.07.2026 | 21.800 ( 0,3 % ) | 556 336 $ | 31.08.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| CUE BIOPHARMA, INC. | Direktor/Vorstandsmitglied | 30.05.2026 |
CommunityHealth NFP
CommunityHealth NFP Medical/Nursing ServicesHealth Services Provides free primary, specialty care, women's health, behavioral health, pharmacy and preventive healthcare services | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
| ATHERSYS, INC. | Vorstandsvorsitzender | 31.12.2023 |
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Corporate Officer/Principal | 01.02.2022 |
Clarus Therapeutics, Inc.
Clarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products for men hypogonadism | Vertrieb & Marketing | 01.09.2015 |
Astellas Pharma US, Inc.
Astellas Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01.01.2004 |
Immedica Pharma AB
Immedica Pharma AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develops medicines for rare, genetic and metabolic diseases, hematology & oncology and specialty care | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 9 |
|---|---|
Rochester Christian University
Rochester Christian University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clarus Therapeutics, Inc.
Clarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products for men hypogonadism | Health Technology |
Horizon Therapeutics Ltd. (Ireland)
Horizon Therapeutics Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Discovers, develops and manufactures pharmaceuticals for autoimmune & inflammatory diseases | Health Technology |
Astellas Pharma US, Inc.
Astellas Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Athersys, Inc.
Athersys, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops novel and proprietary therapies | Health Technology |
Immedica Pharma AB
Immedica Pharma AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develops medicines for rare, genetic and metabolic diseases, hematology & oncology and specialty care | Health Technology |
CommunityHealth NFP
CommunityHealth NFP Medical/Nursing ServicesHealth Services Provides free primary, specialty care, women's health, behavioral health, pharmacy and preventive healthcare services | Health Services |
Kellogg School of Management
Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cue Biopharma, Inc.
Cue Biopharma, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen